Haisco Pharmaceutical Group
Haisco Pharmaceutical Group Co Ltd is a Chinese multinational pharmaceutical and biotechnology enterprise specializing in the research, development, manufacturing, and commercialization of innovative prescription pharmaceutical drugs, specialized therapeutics, and complex chemical formulations. The company produces advanced central nervous system drugs, gastrointestinal medications, anti-infectives, and parenteral nutrition products supplied to hospitals and medical institutions across China. Its core business operations encompass pharmaceutical drug manufacturing, clinical research development, chemical synthesis, and commercial pharmaceutical distribution. Revenue is derived primarily from the wholesale sale of specialty prescription pharmaceutical drugs to medical distributors and hospitals. Haisco Pharmaceutical Group holds a leading market position in specialty pharmaceutical manufacturing in China. The company is headquartered in Chengdu, Sichuan Province, China, and its shares trade on the Shenzhen Stock Exchange.
3 of the funds FundTelligence covers report a position in Haisco Pharmaceutical Group.
- Legal name
- Haisco Pharmaceutical Group Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 3
Funds holding Haisco Pharmaceutical Group
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.02 % (full portfolio disclosed, September 2026)
- KLP AksjeFremvoksende Markeder Indeks — KLP · 0.01 % (full portfolio disclosed, June 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.0 % (full portfolio disclosed, October 2026)